1. Home
  2. WSC vs LQDA Comparison

WSC vs LQDA Comparison

Compare WSC & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo WillScot Mobile Mini Holdings Corp.

WSC

WillScot Mobile Mini Holdings Corp.

HOLD

Current Price

$19.08

Market Cap

3.1B

Sector

Industrials

ML Signal

HOLD

LQDA

Liquidia Corporation

HOLD

Current Price

$40.18

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WSC
LQDA
Founded
1944
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Misc Corporate Leasing Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
3.1B
IPO Year
2015
2020

Fundamental Metrics

Financial Performance
Metric
WSC
LQDA
Price
$19.08
$40.18
Analyst Decision
Buy
Strong Buy
Analyst Count
8
11
Target Price
$24.14
$41.00
AVG Volume (30 Days)
1.8M
952.0K
Earning Date
04-30-2026
05-07-2026
Dividend Yield
1.47%
N/A
EPS Growth
N/A
51.81
EPS
N/A
N/A
Revenue
$2,281,446,000.00
$158,320,000.00
Revenue This Year
N/A
$278.87
Revenue Next Year
$3.54
$57.13
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1031.18
52 Week Low
$14.91
$11.85
52 Week High
$31.88
$46.67

Technical Indicators

Market Signals
Indicator
WSC
LQDA
Relative Strength Index (RSI) 52.59 61.28
Support Level $18.49 $31.75
Resistance Level $19.63 $46.67
Average True Range (ATR) 0.81 1.84
MACD 0.28 0.29
Stochastic Oscillator 78.78 89.80

Price Performance

Historical Comparison
WSC
LQDA

About WSC WillScot Mobile Mini Holdings Corp.

WillScot Holdings Corp designs, delivers, and services on-site, on-demand space solutions for clients. The company offers turnkey solutions in construction, education, manufacturing, retail, healthcare, and entertainment sectors. The products of the company include modular office complexes, mobile offices, classrooms, blast-resistant modules, clearspan structures, sanitation solutions, portable storage containers, and climate-controlled containers and trailers.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.

Share on Social Networks: